Literature DB >> 15567721

High expression during neurogenesis but not mammogenesis of a murine homologue of the Deleted in Breast Cancer2/Rhobtb2 tumor suppressor.

Benoit St-Pierre1, Zhe Jiang, Sean E Egan, Eldad Zacksenhaus.   

Abstract

Deleted in Breast Cancer-2, Dbc2, identified as a candidate tumor suppressor gene for breast cancer and other human malignancies, is a member of a novel gene family encoding putative small GTPases designated as Rhobtb. In this report, we describe the spatio-temporal expression of mDbc2/Rhobtb2 mRNA during mammary gland development and embryogenesis in the mouse. We have first determined that mDbc2/Rhobtb2 transcripts are expressed at low, but seemingly constant levels during mammopoiesis. Secondly, we have found that mDbc2/Rhobtb2 is expressed highly and specifically in the central and peripheral nervous systems during mouse embryogenesis. While our results do not reveal any connection between elevated expression of mDbc2/Rhobtb2 and a specific stage of mammary gland development, they strongly support a role for this gene during development of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15567721     DOI: 10.1016/j.modgep.2004.07.009

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  4 in total

1.  Characterization of RhoBTB-dependent Cul3 ubiquitin ligase complexes--evidence for an autoregulatory mechanism.

Authors:  Jessica Berthold; Kristína Schenková; Sonia Ramos; Yoshie Miura; Manabu Furukawa; Pontus Aspenström; Francisco Rivero
Journal:  Exp Cell Res       Date:  2008-09-20       Impact factor: 3.905

2.  Missense Variants in RHOBTB2 Cause a Developmental and Epileptic Encephalopathy in Humans, and Altered Levels Cause Neurological Defects in Drosophila.

Authors:  Jonas Straub; Enrico D H Konrad; Johanna Grüner; Annick Toutain; Levinus A Bok; Megan T Cho; Heather P Crawford; Holly Dubbs; Ganka Douglas; Rebekah Jobling; Diana Johnson; Bryan Krock; Mohamad A Mikati; Addie Nesbitt; Joost Nicolai; Meredith Phillips; Annapurna Poduri; Xilma R Ortiz-Gonzalez; Zöe Powis; Avni Santani; Lacey Smith; Alexander P A Stegmann; Constance Stumpel; Maaike Vreeburg; Anna Fliedner; Anne Gregor; Heinrich Sticht; Christiane Zweier
Journal:  Am J Hum Genet       Date:  2017-12-21       Impact factor: 11.043

3.  RhoBTB3 Regulates Proliferation and Invasion of Breast Cancer Cells via Col1a1.

Authors:  Kyungho Kim; Youn-Jae Kim
Journal:  Mol Cells       Date:  2022-06-14       Impact factor: 4.250

4.  Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia.

Authors:  Peng Liu; Qinghai Ma; Hanxiang Chen; Li Zhang; Xiaoning Zhang
Journal:  Aging (Albany NY)       Date:  2021-06-01       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.